Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB4594 in advanced cancer
ISRCTN26628699Phase 2Recruiting
- Sponsor
- Cancer Research UK
- Start
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of UCB4594, sponsored by Cancer Research UK. Started Jun 2024; status: recruiting.
02
Drugs
UCB4594
Beyond the preview
Go deeper on ISRCTN26628699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26628699.